Firma Fresenius SE & Co. KGaA, Autor bei PR-Web

Annual General Meeting: Course set for #FutureFresenius – Company heading in the right direction

Posted on 17. May 202320. May 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged clinical, company, dividend, fresenius, helios, kabi, medtech, new, report, risks, shareholders, statements, supervisory, therapy, with

The health care group Fresenius is making good progress with its realignment. “We have worked hard in recent months. We have set fundamental things in motion. Today, Fresenius has a clear focus and a clear strategic direction,” Fresenius CEO Michael […]

Fresenius Medical Care underlines commitment towards gender equity in the workplace, signing United Nations Women’s Empowerment Principles

Posted on 12. April 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged any, clinical, company, financial, forwardlooking, fresenius, medical, new, renal, report, risks, securities, statements, weps, with

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, adopts United Nations (UN) Women’s Empowerment Principles, established by the UN Global Compact and UN Women. The Women’s Empowerment Principles (WEPs) are a set […]

Fresenius with new strategy and clear focus

Posted on 22. February 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged ccr, dialysis, dividend, ebit, ebitda, fiscal, fme25, fresenius, helios, kabi, mabxience, market, patients, revenue, with

Intention to deconsolidate Fresenius Medical Care by changing the legal form of FMC to a German Stock Corporation (“Aktiengesellschaft”) Focus on Operating Companies Fresenius Kabi and Fresenius Helios Active portfolio management for assets where Fresenius lacks best ownership New, […]

Fresenius strengthens its Management Board team – New appointment at Fresenius Kabi – Expansion of Human Resources/Legal to include ESG

Posted on 22. February 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged angelini, biosimilars, brain, energy, enerjisa, eon, ESG, fresenius, kabi, market, merck, patients, statements, uniper, with

Pierluigi Antonelli takes over as Chairman of the Management Board of Fresenius Kabi Sebastian Biedenkopf to leave the company at the end of his contract Michael Moser to assume responsibility for Human Resources, Risk Management, Legal as well as Environmental, […]

Fresenius Medical Care takes action to close global health gaps, signs “Zero Health Gaps” Pledge at the World Economic Forum

Posted on 20. January 202320. January 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged any, cares, clinical, covid, dialysis, fme, fresenius, medical, patients, renal, risks, securities, statements, treatment, with

Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases, has taken the Zero Health Gaps Pledge at the World Economic Forum in Davos, Switzerland. The Zero Health Gaps Pledge is part of […]

Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care

Posted on 6. December 2022 by Firma Fresenius SE & Co. KGaA Posted in General Tagged cares, clinical, financial, fme25, fresenius, kriwet, medical, new, patients, renal, risks, securities, statements, supervisory, with

Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she was Deputy CEO of Fresenius Medical Care. The Supervisory […]

Fresenius appoints Dennis Hofmann as Head of Corporate Communications

Posted on 1. December 20221. December 2022 by Firma Fresenius SE & Co. KGaA Posted in General Tagged clinical, comms, company, express, fresenius, healthcare, kabi, leoni, new, report, risks, siemens, statements, strong, with

Dennis Hofmann has been appointed Head of Global Corporate Communications at Fresenius. He succeeds the previous Head of Communications Matthias Link, who will leave the company after 14 years by mutual agreement end of 2022. In his new role, Dennis […]

Fresenius successfully places bonds with a volume of 1 billion euros

Posted on 22. November 2022 by Firma Fresenius SE & Co. KGaA Posted in General Tagged america, bonds, clinical, company, financial, fresenius, kid, market, priips, prospectus, risks, securities, statements, transaction, with

Fresenius today successfully placed bonds with an aggregate volume of €1 billion across two tranches: – €500 million bonds with a maturity in May 2026 and an annual coupon of 4.25% and – €500 million bonds with a maturity in […]